Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Metagenomi, Inc. | Chief Medical Officer | Common Stock | 100K | $289K | $2.88 | Apr 1, 2024 | Direct |
MARINUS PHARMACEUTICALS, INC. | Director | Common Stock | 14.1K | $60.3K | $4.28 | Jun 18, 2024 | Direct |
Metagenomi, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 243K | Apr 1, 2024 | Direct | ||
Protagonist Therapeutics, Inc | Director | Stock Option (right to buy) | 30K | Jan 16, 2023 | Direct | ||
MARINUS PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 10.5K | Jun 18, 2024 | Direct | ||
Neurogene Inc. | Director | Stock Option (Right to Buy) | 7.7K | Jun 14, 2024 | Direct |